Загрузка страницы

Treatments Gleason 3+4 & Gleason 4+3 Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD

Alex asks medical oncologist Mark Scholz, MD all about the best treatments for men with Teal (intermediate-risk) prostate cancer. These range from active surveillance for men with Low-Teal to combination therapy with radiation and hormone therapy for men with High-Teal prostate cancer.

0:05 Should a Low-Teal patient (favorable intermediate-risk) with Gleason 3+4 get a second biopsy or a second opinion before committing to active surveillance?

1:30 What is the typical treatment for men with Basic-Teal (intermediate-risk without favorable or unfavorable features)?

2:55 What is the imaging process like for Basic-Teal and High-Teal (intermediate-risk with unfavorable features) men?

3:48 How does seminal vesicle invasion or lymph node involvement change the staging for a man with Gleason 4+3?

4:14 Should patients with Basic or High-Teal prostate cancer still consider quality of life when deciding on treatment?

5:25 What is the monitoring process like for patients undergoing short-term hormone therapy?

6:20 Can a patient in the Teal category (intermediate-risk) go into a permanent remission?

Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org

To learn more about prostate cancer visit http://www.pcri.org

Follow our PCRI Mascot, Hunter: https://www.instagram.com/sirhunterthedal

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.

The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.

#ProstateCancer #Prostate #MarkScholzMD

Видео Treatments Gleason 3+4 & Gleason 4+3 Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD канала Prostate Cancer Research Institute
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
9 марта 2021 г. 21:00:10
00:07:18
Другие видео канала
Treatment Strategies for Gleason 3+4=7 vs. 4+3=7 | Ask a Prostate Cancer Expert, Mark Scholz, MDTreatment Strategies for Gleason 3+4=7 vs. 4+3=7 | Ask a Prostate Cancer Expert, Mark Scholz, MDGleason 3+4 Active Surveillance, PSMA Alternatives, and More | Answering YouTube Comments #46 | PCRIGleason 3+4 Active Surveillance, PSMA Alternatives, and More | Answering YouTube Comments #46 | PCRIAn Overview of Gleason 3+4 & Gleason 4+3 Prostate Cancer | Ask A Prostate Expert, Mark Scholz, MDAn Overview of Gleason 3+4 & Gleason 4+3 Prostate Cancer | Ask A Prostate Expert, Mark Scholz, MDRadical Prostatectomy for Basic Teal Prostate Cancer | Prostate Cancer Staging GuideRadical Prostatectomy for Basic Teal Prostate Cancer | Prostate Cancer Staging GuideActive Surveillance in Favorable Intermediate-Risk Prostate CancerActive Surveillance in Favorable Intermediate-Risk Prostate CancerNutrition Program for Prostate Cancer Recovery Presented by David A. Levy, MDNutrition Program for Prostate Cancer Recovery Presented by David A. Levy, MDUnderstanding PSA, PIRADS, Tumor Size, & Location | Answering YouTube Comments #59 | Mark Scholz, MDUnderstanding PSA, PIRADS, Tumor Size, & Location | Answering YouTube Comments #59 | Mark Scholz, MDUnderstanding The Gleason Score | Prostate Cancer Staging GuideUnderstanding The Gleason Score | Prostate Cancer Staging GuideWhy Doctors Don't Talk About Brachytherapy | Ask a Prostate Expert, Mark Scholz, MDWhy Doctors Don't Talk About Brachytherapy | Ask a Prostate Expert, Mark Scholz, MDLow Risk (Gleason 3+3=6) & Intermediate Risk (Gleason 3+4=7) Prostate Cancer Q+A | PCRI #13Low Risk (Gleason 3+3=6) & Intermediate Risk (Gleason 3+4=7) Prostate Cancer Q+A | PCRI #13Which is Better - Surgery vs. Radiation for Prostate Cancer?Which is Better - Surgery vs. Radiation for Prostate Cancer?Why Prostate Cancer Survivor John Shearron Thinks It’s Important To Do Your Research | PCRIWhy Prostate Cancer Survivor John Shearron Thinks It’s Important To Do Your Research | PCRIGleason 4+4=8 Prostate Cancer Treatments | Ask a Prostate Expert, Mark Scholz, MDGleason 4+4=8 Prostate Cancer Treatments | Ask a Prostate Expert, Mark Scholz, MDHow Much Safer is Modern Radiation Therapy? | Answering YouTube Comments #63 | Mark Scholz, MDHow Much Safer is Modern Radiation Therapy? | Answering YouTube Comments #63 | Mark Scholz, MDIs Prostate Cancer Fatal? | Ask A Prostate Expert, Mark Scholz, MDIs Prostate Cancer Fatal? | Ask A Prostate Expert, Mark Scholz, MDGleason 3+4=7 and 4+3=7: What Is The Difference? | Ask a Prostate Expert, Mark Scholz, MDGleason 3+4=7 and 4+3=7: What Is The Difference? | Ask a Prostate Expert, Mark Scholz, MDProstate Cancer and Gleason Score or Group VideoProstate Cancer and Gleason Score or Group VideoA Dummies Guide to Contemporary Gleason grading of Prostate Cancer-Definition Of GradesA Dummies Guide to Contemporary Gleason grading of Prostate Cancer-Definition Of GradesImmunotherapy in 2022: Provenge, Keytruda, Car-T, and Leukine for Prostate Cancer | Mark Scholz, MDImmunotherapy in 2022: Provenge, Keytruda, Car-T, and Leukine for Prostate Cancer | Mark Scholz, MDWhat Should the PSA be After Prostate Cancer Surgery? | Ask a Prostate Expert, Mark Scholz, MDWhat Should the PSA be After Prostate Cancer Surgery? | Ask a Prostate Expert, Mark Scholz, MD
Яндекс.Метрика